Want to see ES:NTH full AI Analyst Report?
Top Page
Naturhouse Health
(BME:NTH)
Select Model
Select Model
Rating:70Outperform
Price Target:
€3.00
▲(30.43% Upside)
Action:Reiterated
Date:04/09/26
The score is driven primarily by solid financial fundamentals (strong profitability, cash flow, and low leverage) but tempered by a severe 2025 revenue decline and reduced equity. Valuation is attractive (low P/E and high dividend yield), while technicals show a stable uptrend with only moderate momentum.
Positive Factors
High Profitability / Margins
Consistently elevated EBIT and net margins reflect an efficient service-plus-product business model where dietitian-led engagement drives recurring product sales. High margins provide durable earnings quality, absorb revenue volatility, and support reinvestment or shareholder returns over the medium term.
Negative Factors
Severe 2025 Revenue Decline
A dramatic -37.9% revenue drop in 2025, on top of a multi-year shrinking top line, threatens the recurring product-sales engine and undermines scale benefits. If top-line contraction persists, it can erode the company’s ability to sustain margins, franchise economics, and long-term earnings durability.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability / Margins
Consistently elevated EBIT and net margins reflect an efficient service-plus-product business model where dietitian-led engagement drives recurring product sales. High margins provide durable earnings quality, absorb revenue volatility, and support reinvestment or shareholder returns over the medium term.
Read all positive factors
Naturhouse Health (NTH) vs. iShares MSCI Spain ETF (EWP)
Market Cap
€154.67M
Dividend Yield11.15%
Average Volume (3M)24.74K
Price to Earnings (P/E)18.8
Beta (1Y)0.23
Revenue Growth-3.63%
EPS Growth2.37%
CountryES
Employees191
SectorHealthcare
Sector Strength45
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.16
Shares Outstanding60,000,000
10 Day Avg. Volume17,416
30 Day Avg. Volume24,740
Financial Highlights & Ratios
PEG Ratio2.07
Price to Book (P/B)7.36
Price to Sales (P/S)2.74
P/FCF Ratio11.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.15
Revenue Forecast (FY)€48.10M
Naturhouse Health Business Overview & Revenue Model
Company Description
Naturhouse Health, S.A. is a prominent entity in the global nutrition and weight management sector, maintaining a significant presence across Spain, Italy, France, Poland, and numerous other international markets. The company provides a diverse ar...
How the Company Makes Money
NTH primarily makes money through (1) retail sales of its own nutrition and diet-related products to clients attending Naturhouse centers and (2) fees and economics derived from operating a branded center network (notably via franchising). In prac...
Naturhouse Health Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.81M | 47.63M | 49.42M | 50.41M | 52.40M | 57.59M |
| Gross Profit | 34.47M | 12.94M | 35.46M | 25.11M | 37.48M | 41.26M |
| EBITDA | 13.43M | 14.45M | 15.63M | 17.93M | 15.61M | 20.80M |
| Net Income | 10.23M | 10.09M | 9.86M | 11.29M | 9.63M | 13.36M |
Balance Sheet | ||||||
| Total Assets | 43.70M | 33.43M | 42.59M | 48.85M | 42.82M | 49.00M |
| Cash, Cash Equivalents and Short-Term Investments | 23.34M | 14.57M | 21.67M | 27.10M | 14.78M | 27.25M |
| Total Debt | 2.72M | 3.43M | 4.27M | 5.05M | 5.38M | 4.37M |
| Total Liabilities | 17.86M | 15.68M | 10.91M | 18.21M | 14.96M | 12.92M |
| Stockholders Equity | 25.83M | 17.75M | 31.68M | 30.63M | 27.81M | 36.02M |
Cash Flow | ||||||
| Free Cash Flow | 10.91M | 11.48M | 11.22M | 20.38M | 6.13M | 16.12M |
| Operating Cash Flow | 11.64M | 12.15M | 11.56M | 20.95M | 7.10M | 16.17M |
| Investing Cash Flow | 163.00K | -420.00K | 862.00K | -459.00K | -5.22M | -4.27M |
| Financing Cash Flow | -14.92M | -18.95M | -16.10M | -7.70M | -16.98M | -6.27M |
Naturhouse Health Technical Analysis
Positive
2.30
Price Trends
2.55
Positive
2.53
Positive
2.30
Positive
Market Momentum
<0.01
Negative
56.66
Neutral
74.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:NTH, the sentiment is Positive. The current price of 2.3 is below the 20-day moving average (MA) of 2.55, below the 50-day MA of 2.55, and below the 200-day MA of 2.30, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.66 is Neutral, neither overbought nor oversold. The STOCH value of 74.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ES:NTH.
Naturhouse Health Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | €154.67M | 18.85 | 38.28% | 11.15% | -3.63% | 2.37% | |
70 Outperform | €9.09B | 15.36 | 15.69% | ― | 5.27% | 11.89% | |
66 Neutral | €2.75B | 13.05 | 9.45% | 3.50% | -4.04% | 3.37% | |
57 Neutral | €2.40B | 18.27 | 1180.47% | ― | -2.81% | ― | |
55 Neutral | €149.00M | -11.00 | -13.27% | ― | -17.63% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | €7.18M | -89.29 | ― | ― | 105.84% | -113.88% |
* Healthcare Sector Average
ES:NTH
Naturhouse Health
2.58
0.94
57.32%
ES:DIA
DISTRIBUIDORA INTERNACIONAL DE ALIMENTACION
41.30
13.75
49.91%
ES:EBRO
EBRO FOODS
17.88
0.94
5.57%
ES:PVA
Pescanova
0.25
-0.06
-19.61%
ES:OLE
DEOLEO S.A.
0.30
0.11
60.22%
ES:PUIG
Puig Brands, S.A.
16.13
-0.65
-3.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.